Hudson Bay Capital Management LP Gilead Sciences, Inc. Transaction History

Hudson Bay Capital Management LP

$21.9 Billion
Q3 2024

A detailed history of Hudson Bay Capital Management LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 110,000 shares of GILD stock, worth $9.72 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

110,000

Previous 145,000 24.14%

Holding current value

$9.72 Million

Previous $9.95 Million 7.32%

% of portfolio

0.04%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $4.27 Million - $5.39 Million	-64,147 Reduced 44.24%	80,853 $6.78 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $20.8 Million - $24 Million	-329,108 Reduced 69.42%	145,000 $9.95 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $30.5 Million - $37.2 Million	426,608 Added 898.12%	474,108 $34.7 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $14.7 Million - $16.6 Million	-200,000 Reduced 80.81%	47,500 $3.85 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $14.3 Million - $15.6 Million	193,100 Added 354.96%	247,500 $18.5 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $4.13 Million - $4.72 Million	54,400 New	54,400 $4.19 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $1.44 Million - $1.63 Million	25,000 New	25,000 $1.55 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $2.1 Million - $2.4 Million	-35,000 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $2.83 Million - $3.23 Million	-50,000 Reduced 58.82%	35,000 $2.04 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $5.28 Million - $6.64 Million	85,000 New	85,000 $5.37 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $5.95 Million - $7.62 Million	-95,000 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $5.24 Million - $5.76 Million	85,000 Added 850.0%	95,000 $6.17 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $625,100 - $690,000	-10,000 Reduced 50.0%	10,000 $634,000
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $928,050 - $1.04 Million	-15,000 Reduced 42.86%	20,000 $1.35 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $2.19 Million - $2.45 Million	35,000 New	35,000 $2.28 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $175,176 - $204,336	-2,700 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $196,668 - $239,760	2,700 New	2,700 $204,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Gilead Sciences, Inc. Transaction History